Alliance Trust PLC : Director/PDMR Shareholding

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
40
Alliance Trust PLC : Director/PDMR Shareholding

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and their Closely Associated Persons

The following Director has purchased ordinary shares of 2.5 pence each in Alliance Trust PLC as detailed below.

Director Purchase date Number of shares purchased Price paid per share (£) Resultant interest in shares
Karl Sternberg 10.04.17 14 6.88795 3,092

The following notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

  Details of the person discharging managerial responsibilities/person closely associated
  Name Karl Sternberg
  Reason for notification
  Position/Status Non-Executive Director
  Initial notification/Amendment Increase in beneficial interest following purchase of shares (within Investment Dealing Account pursuant to regular standing instruction).
  Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
  Name Alliance Trust PLC
  LEI 213800SZZD4E2IOZ9W55
  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
  Description of the financial instrument, type of instrument Ordinary Shares of 2.5 pence each in Alliance Trust PLC
        Identification code Identification code for Alliance Trust PLC shares: GB00B11V7W98
  Nature of transaction Purchase of Ordinary Shares
  Price(s) and volume(s) Price(s) Volume(s)
£6.88795 14
  Aggregated Information Aggregated volume Price Not applicable - Single transaction
  Date of transaction 10 April 2017
  Place of transaction London Stock Exchange, Main Market (XLON)
Name of contact Ian Anderson
Telephone Number +44 (0)1382 321238
Date of notification 10 April 2017
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading